The Latest

Missed our "Last Investors Webinar"? No worries! The recordings are now available for you to watch at your convenience. Dive into insightful discussions with our company leaders, explore innovative investment strategies, and gain valuable knowledge about the healthcare data market.Whether you’re a seasoned investor or just starting out, this is an opportunity you won’t want to miss!Access the full recordings and empower your investment journey today!

Data: The World’s Most Precious Commodity In the 21st Century, data is the raw material upon which all value-added transactions depend. Manufacturing, , finance, transportation, energy and countless other industries all heavily rely on data to innovate, compete and indeed survive. This is nowhere more true than in healthcare. The $60 billion healthcare data market is growing at over 11% per year. The largest consumer of data will be AI, if it is not already. Indeed, AI is fast running out of training data. This puts a premium on private sources of relevant and high quality data. As with all raw material, clear proof of data ownership is critical. Who Owns That Data? Failure to establish data ownership invites litigation, and the inability to successfully monetize or otherwise use it. For example, in December 2023 the New York Times sued OpenAI and Microsoft for copyright infringement, seeking billions of dollars in damages. This month, Thomson Reuters won a landmark AI copyright infringement case. The federal court held that the defendant used content from Thomson Reuters to develop a competing AI-driven legal research tool. The judge ruled that the defendant’s actions did not qualify as "fair use" under U.S. copyright law. This landmark decision underscores the legal protections surrounding the use of copyrighted materials in AI training and development. This Is Yet One More Challenge For “Big Data” And Healthcare AI Models AI in medicine is already here, and will only become more pervasive. However, the data on which AI healthcare models train is typically of poor quality. Problems include incompleteness, inability to audit original sources, no or irrelevant clinical context, data “cleaning” and other unknown manipulations, irreconcilable data conflicts, no correlated outcomes measures, and stale or undated information. Most of today’s $60 bn. data market represents the exchange and repackaging of such “big data”. AI error rates and “hallucinations” are thus not only inevitable in most AI healthcare solutions, they are dangerous in specific applications such as clinical decision-making. But now there is a deeper problem – who owns the various bits and pieces of data making up a “big data” dataset? EMR companies, medical society registries, hospital systems, researchers, payers, AI start-ups are among the many entities who may have contributed and will claim ownership. The weaknesses of “big data” structures, coupled with competing ownership claims, will make it an increasingly unattractive choice for healthcare data consumers, including AI models. The Circles Solution RegenMed’s Circle datasets are generated and maintained in a closed system which maintains their coherence, transparency, and auditability. They are high-quality – both statistically and clinically significant – with clear ownership and monetization rights vested in the dataset creators. Real world data is likely to become one of the most critical categories of all healthcare data. It will be key to supporting value based medicine, lower costs, faster lab-to-bedside clinical translation, and health equity. RegenMed is well positioned to capture a significant portion of this market.

‍The Large and Growing MarketHealthcare is undergoing a paradigm shift. With rising chronic diseases, escalating healthcare costs, and growing dissatisfaction with conventional treatments, patients are turning to Complementary and Alternative Medicine (CAM). CAM is no longer seen as fringe medicine. It is now a mainstream movement, with increasing adoption in hospitals, clinics, and even corporate wellness programs. Over 50% of U.S. physicians recommended at least one complementary health approach to their patients within a 12-month period. 1One-third of Americans use CAM alongside conventional treatments. In Europe, 25-50% of the population uses CAM therapies, including homeopathy, naturopathy, and herbal medicine. In Asia, Traditional Chinese Medicine (TCM) and Ayurveda are deeply embedded in cultural and medical systems. 2The Global CAM Market is valued at $100–$400 billion, with a projected growth rate of 15–25%. The U.S. CAM market is valued at over $50 billion 3. Factors driving this growth include:Patients are more proactive about their health.More people are seeking alternative solutions for pain, inflammation, and metabolic disorders.CAM aligns with the booming self-care, fitness, and mental health movements.AI-powered health platforms, wearable biofeedback devices, and personalized wellness programs are making CAM more accessible.Major corporations, insurance providers, and even governments are beginning to integrate CAM into healthcare policies and benefits. 4True healthcare innovation lies in integration — combining the best of conventional medicine with evidence-based CAM therapies.Chronic Disease Management: CAM therapies like acupuncture, herbal medicine, and functional nutrition help manage diabetes, cardiovascular diseases, and autoimmune disorders without heavy reliance on pharmaceuticals.Pain & Opioid Crisis Solutions: Chiropractic care, acupuncture, and red light therapy offer non-drug alternatives for pain management, reducing opioid dependence.Mental Health & Stress Reduction: Meditation, breathwork, and biofeedback therapies help treat anxiety, depression, PTSD, and insomnia — often as effectively as medication.Personalized & Preventive Healthcare: Functional and integrative medicine focus on root causes rather than symptom suppression, reducing long-term healthcare costs.Patient Demand & Market Trends: Hospitals and clinics adopting CAM see higher patient satisfaction, improved treatment outcomes, and increased revenue. 5Several world-renowned institutions, such as Mayo Clinic, Cleveland Clinic, and Johns Hopkins, have already integrated CAM into their healthcare offerings—proving that a blended approach is the future of medicine.RegenMed Is Strongly Positioned To BenefitThere is very little data on integrative, complementary, or alternative medicine procedures. Circles represent a clinical grade yet low-cost approach to generating statistically significant datasets for any individual or combination of procedures. RegenMed is already working with doctors around the world in developing such datasets. They will be critical to:Regulation & Standardization: Governments are creating guidelines to ensure CAM therapies meet safety and efficacy standards.Insurance Expansion: More insurance companies are covering CAM services, recognizing their cost-effectiveness.AI & Digital CAM Platforms: Personalized health recommendations using AI-driven diagnostics.Mainstream Adoption of Holistic Wellness: Corporations are investing in employee wellness programs that integrate CAM.Psychedelic-Assisted Therapy: Psilocybin and MDMA treatments are gaining momentum for mental health breakthroughs.‍‍

Nate Anderson will interview Michael Tierney, Co-Founder and CEO, as well as Dolph Courchaine, Chief Information and Technology Officer.Topics will include:Market dynamicsCompetitive positioningValuation models Open Q & A sessionAnd more‍Date: Tuesday, February 18Time: 6:30 PM EST‍This campaign closes on March 6.Claim Your Place!

Effective February 10, the U.S. government will cut medical research grants by at least $4 billion. This is only one part of an accelerating trend in reducing healthcare expenditures – often by utilizing modern technology. The National Institutes of Health provide funding to thousands of hospitals, medical schools, universities, and independent research organizations. They in turn support more than 300,000 researchers. In many cases, medical science can advance only through expensive laboratories, hundreds of researchers, and associated overhead. In many more cases however, true improvement in healthcare results from letting physicians not researchers lead the way. In other words, the most impactful clinical research is usually developed from the bottom up, not the top down. Today, as in the past, practicing physicians can generate the best informed and therefore most impactful clinical hypotheses. Physicians are an immensely valuable resource which our current approach to medical research fails to utilize. Even in large academic medical institutions, there is a broad divide between research and everyday clinical practice. This is one more reason America spends far more than any other country on healthcare, with generally worse results. RegenMed provides the technical platforms and burden-free processes allowing physicians in any specialty, wherever located, to collaborate on medical research. Medical research which is statistically significant, and can have a positive and broad impact today. Critically, RegenMed delivers these capabilities to physicians and partnering scientists at a far lower price, and with far less burden, than current approaches. It is thus in a strong position to help healthcare institutions deliver genuine value-based medicine.